Owens & Minor (OMI) Competitors $5.66 +0.26 (+4.81%) Closing price 03:59 PM EasternExtended Trading$5.56 -0.11 (-1.86%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock OMI vs. HSIC, MCK, COR, CAH, LMAT, ATRC, QDEL, AHCO, PAHC, and NEOGShould you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include Henry Schein (HSIC), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), LeMaitre Vascular (LMAT), AtriCure (ATRC), QuidelOrtho (QDEL), AdaptHealth (AHCO), Phibro Animal Health (PAHC), and Neogen (NEOG). These companies are all part of the "medical" sector. Owens & Minor vs. Its Competitors Henry Schein McKesson Cencora Cardinal Health LeMaitre Vascular AtriCure QuidelOrtho AdaptHealth Phibro Animal Health Neogen Henry Schein (NASDAQ:HSIC) and Owens & Minor (NYSE:OMI) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Is HSIC or OMI more profitable? Henry Schein has a net margin of 3.05% compared to Owens & Minor's net margin of -13.78%. Owens & Minor's return on equity of 26.59% beat Henry Schein's return on equity.Company Net Margins Return on Equity Return on Assets Henry Schein3.05% 14.36% 5.52% Owens & Minor -13.78%26.59%2.45% Do analysts rate HSIC or OMI? Henry Schein presently has a consensus target price of $75.58, indicating a potential upside of 11.41%. Owens & Minor has a consensus target price of $8.29, indicating a potential upside of 46.50%. Given Owens & Minor's stronger consensus rating and higher possible upside, analysts clearly believe Owens & Minor is more favorable than Henry Schein.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 0 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.33Owens & Minor 2 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.43 Does the media prefer HSIC or OMI? In the previous week, Owens & Minor had 12 more articles in the media than Henry Schein. MarketBeat recorded 45 mentions for Owens & Minor and 33 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.14 beat Owens & Minor's score of 0.29 indicating that Henry Schein is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Henry Schein 20 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Owens & Minor 7 Very Positive mention(s) 4 Positive mention(s) 13 Neutral mention(s) 8 Negative mention(s) 3 Very Negative mention(s) Neutral Do insiders & institutionals hold more shares of HSIC or OMI? 96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 98.0% of Owens & Minor shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by company insiders. Comparatively, 3.7% of Owens & Minor shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more risk and volatility, HSIC or OMI? Henry Schein has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 1.04, meaning that its stock price is 4% more volatile than the S&P 500. Which has higher valuation and earnings, HSIC or OMI? Henry Schein has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHenry Schein$12.67B0.65$390M$3.1021.88Owens & Minor$10.70B0.04-$362.69M-$15.63-0.36 SummaryHenry Schein beats Owens & Minor on 9 of the 17 factors compared between the two stocks. Get Owens & Minor News Delivered to You Automatically Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMI vs. The Competition Export to ExcelMetricOwens & MinorMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$417.12M$10.61B$5.63B$20.96BDividend YieldN/A1.97%3.79%3.59%P/E Ratio-0.3613.0121.9025.57Price / Sales0.0431.58465.6755.97Price / Cash0.6024.3737.4023.77Price / Book-1.553.399.095.26Net Income-$362.69M$209.94M$3.25B$994.11M7 Day Performance-19.83%5.30%4.76%1.78%1 Month Performance-27.16%11.01%6.72%2.03%1 Year Performance-64.82%-9.06%30.51%12.80% Owens & Minor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMIOwens & Minor4.8932 of 5 stars$5.66+4.8%$8.29+46.5%-65.2%$417.12M$10.70B-0.3623,200News CoverageEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap UpHSICHenry Schein4.169 of 5 stars$70.02+3.0%$78.08+11.5%-0.9%$8.52B$12.67B21.8825,000Positive NewsMCKMcKesson4.5041 of 5 stars$710.63+1.7%$710.17-0.1%+22.0%$88.91B$359.05B27.5145,000Positive NewsAnalyst ForecastCORCencora4.4814 of 5 stars$293.52+1.8%$309.83+5.6%+24.2%$56.89B$293.96B34.0546,000Positive NewsAnalyst ForecastCAHCardinal Health4.8244 of 5 stars$158.64+1.7%$158.07-0.4%+41.4%$37.86B$226.83B24.7548,900Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionLMATLeMaitre Vascular2.1368 of 5 stars$84.36+4.1%$97.83+16.0%+16.8%$1.91B$219.86M42.61490News CoverageInsider TradeATRCAtriCure3.1078 of 5 stars$36.35+5.6%$50.89+40.0%+57.2%$1.71B$465.31M0.001,300Short Interest ↑QDELQuidelOrtho4.3261 of 5 stars$24.11+5.7%$44.33+83.9%-40.4%$1.63B$2.78B-4.856,600AHCOAdaptHealth3.9928 of 5 stars$9.11+4.1%$13.40+47.1%-2.6%$1.18B$3.26B11.9910,500PAHCPhibro Animal Health3.7108 of 5 stars$27.14+3.9%$24.40-10.1%+75.8%$1.10B$1.02B34.801,940NEOGNeogen3.558 of 5 stars$4.68+0.4%$7.50+60.3%-65.4%$1.02B$894.66M-0.932,110Trending News Related Companies and Tools Related Companies Henry Schein Alternatives McKesson Alternatives Cencora Alternatives Cardinal Health Alternatives LeMaitre Vascular Alternatives AtriCure Alternatives QuidelOrtho Alternatives AdaptHealth Alternatives Phibro Animal Health Alternatives Neogen Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OMI) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.